share_log

EFFECT: Others

EFFECT: Others

EFFECT:其他
美股sec公告 ·  04/22 06:06
Moomoo AI 已提取核心訊息
Adial Pharmaceuticals, Inc. has achieved a significant milestone with the United States Securities and Exchange Commission (SEC) declaring its Form S-3 effective as of April 19, 2024, at 5:00 PM. This form is a registration statement that allows companies to issue various securities to the public. The effectiveness of this form indicates that Adial Pharmaceuticals has met all the necessary regulatory requirements to proceed with the issuance of securities.
Adial Pharmaceuticals, Inc. has achieved a significant milestone with the United States Securities and Exchange Commission (SEC) declaring its Form S-3 effective as of April 19, 2024, at 5:00 PM. This form is a registration statement that allows companies to issue various securities to the public. The effectiveness of this form indicates that Adial Pharmaceuticals has met all the necessary regulatory requirements to proceed with the issuance of securities.
Adial Pharmicals, Inc.取得了重要的里程碑,美國證券交易委員會(SEC)宣佈其S-3表格自2024年4月19日下午5點起生效。該表格是一份註冊聲明,允許公司向公衆發行各種證券。該表格的有效性表明,Adial Pharmicals已經滿足了進行證券發行的所有必要監管要求。
Adial Pharmicals, Inc.取得了重要的里程碑,美國證券交易委員會(SEC)宣佈其S-3表格自2024年4月19日下午5點起生效。該表格是一份註冊聲明,允許公司向公衆發行各種證券。該表格的有效性表明,Adial Pharmicals已經滿足了進行證券發行的所有必要監管要求。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息